SAN FRANCISCO, U.S. and SUZHOU, China, Dec. 3, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

NEWTON, Mass., Dec. 3, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it is in ...

Endometrial cancer is a type of cancer in the lining of the uterus (also known as the endometrium). It is the most common type of gynecologic cancer in women. There are many treatments for endometrial ...

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Patients with endometrial cancer want an individualized, collaborative approach to their treatment plan, according to a recent study.

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial ...

What Is Metastatic Endometrial Cancer? Metastatic endometrial cancer is when cancer that starts in the lining of the uterus (endometrium) spreads to other parts of the body. Your doctor may call it ...

A phase II study is investigating olaparib (Lynparza), cediranib (Recentin), durvalumab (Imfinzi), or investigational capivasertib in various treatment combinations in patients with recurrent, ...

The current study looked at treatment data from 2 randomized trials conducted by the Women’s Health Initiative with long term follow up. The effects of MHT on incidence and mortality from ovarian ...

— First regulatory approval for fruquintinib combination therapy with an immune checkpoint inhibitor — “This approval of fruquintinib plus sintilimab could represent a paradigm shift in managing this ...